Arcturus Therapeutics Holdings Inc.

The current price of ARCT is 26.78 USD — it has increased by 1.75% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Arcturus Therapeutics Holdings Inc. stocks are traded under the ticker ARCT.

Arcturus Therapeutics Holdings Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.

ARCT stock is 3.15% volatile and has beta coefficient of 2.51. Check out the list of the most volatile stocks — is Arcturus Therapeutics Holdings Inc. there?

One year price forecast for Arcturus Therapeutics Holdings Inc. has a max estimate of 140.00 USD and a min estimate of 18.00 USD.

ARCT earnings for the last quarter are −0.61 USD per share, whereas the estimation was −1.69 USD resulting in a 63.94% surprise. The estimated earnings for the next quarter are −0.99 USD per share. See more details about Arcturus Therapeutics Holdings Inc. earnings.

Arcturus Therapeutics Holdings Inc. revenue for the last quarter amounts to ‪45.14 M‬ USD despite the estimated figure of ‪15.85 M‬ USD. In the next quarter revenue is expected to reach ‪37.86 M‬ USD.

Yes, you can track Arcturus Therapeutics Holdings Inc. financials in yearly and quarterly reports right on TradingView.

ARCT net income for the last quarter is ‪−8.57 M‬ USD, while the quarter before that showed ‪−16.22 M‬ USD of net income which accounts for 47.15% change. Track more Arcturus Therapeutics Holdings Inc. financial stats to get the full picture.

Today Arcturus Therapeutics Holdings Inc. has the market capitalization of ‪708.41 M‬, it has decreased by 4.00% over the last week.

No, ARCT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, ARCT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Arcturus Therapeutics Holdings Inc. stock right from TradingView charts — choose your broker and connect to your account.

ARCT reached its all-time high on Oct 4, 2013 with the price of 188.72 USD, and its all-time low was 4.11 USD and was reached on Dec 28, 2018.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 180.00 employees. See our rating of the largest employees — is Arcturus Therapeutics Holdings Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Arcturus Therapeutics Holdings Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Arcturus Therapeutics Holdings Inc. stock shows the sell signal. See more of Arcturus Therapeutics Holdings Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Arcturus Therapeutics Holdings Inc. future price: according to them, ARCT price has a max estimate of 140.00 USD and a min estimate of 18.00 USD. Read a more detailed Arcturus Therapeutics Holdings Inc. forecast: see what analysts think of Arcturus Therapeutics Holdings Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Arcturus Therapeutics Holdings Inc. EBITDA is ‪−4.02 M‬ USD, and current EBITDA margin is −0.76%. See more stats in Arcturus Therapeutics Holdings Inc. financial statements.